3-12609349-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002880.4(RAF1):​c.321-14T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00059 in 1,541,572 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00056 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00059 ( 8 hom. )

Consequence

RAF1
NM_002880.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.987

Publications

0 publications found
Variant links:
Genes affected
RAF1 (HGNC:9829): (Raf-1 proto-oncogene, serine/threonine kinase) This gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration. Mutations in this gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2. [provided by RefSeq, Jul 2008]
RAF1 Gene-Disease associations (from GenCC):
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Noonan syndrome 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, G2P
  • dilated cardiomyopathy 1NN
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • LEOPARD syndrome 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 3-12609349-A-T is Benign according to our data. Variant chr3-12609349-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 178110.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAdExome4 allele frequency = 0.000594 (826/1390468) while in subpopulation EAS AF = 0.0169 (665/39336). AF 95% confidence interval is 0.0158. There are 8 homozygotes in GnomAdExome4. There are 402 alleles in the male GnomAdExome4 subpopulation. Median coverage is 25. This position passed quality control check.
BS2
High AC in GnomAd4 at 84 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002880.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAF1
NM_002880.4
MANE Select
c.321-14T>A
intron
N/ANP_002871.1
RAF1
NM_001354689.3
c.321-14T>A
intron
N/ANP_001341618.1
RAF1
NM_001354690.3
c.321-14T>A
intron
N/ANP_001341619.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAF1
ENST00000251849.9
TSL:1 MANE Select
c.321-14T>A
intron
N/AENSP00000251849.4
RAF1
ENST00000442415.7
TSL:5
c.321-14T>A
intron
N/AENSP00000401888.2
RAF1
ENST00000685653.1
c.321-14T>A
intron
N/AENSP00000509968.1

Frequencies

GnomAD3 genomes
AF:
0.000556
AC:
84
AN:
150978
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000667
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0147
Gnomad SAS
AF:
0.000838
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00108
AC:
266
AN:
245888
AF XY:
0.000960
show subpopulations
Gnomad AFR exome
AF:
0.0000622
Gnomad AMR exome
AF:
0.0000306
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0150
Gnomad FIN exome
AF:
0.0000468
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.000498
GnomAD4 exome
AF:
0.000594
AC:
826
AN:
1390468
Hom.:
8
Cov.:
25
AF XY:
0.000578
AC XY:
402
AN XY:
695758
show subpopulations
African (AFR)
AF:
0.0000313
AC:
1
AN:
31964
American (AMR)
AF:
0.0000448
AC:
2
AN:
44594
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25726
East Asian (EAS)
AF:
0.0169
AC:
665
AN:
39336
South Asian (SAS)
AF:
0.000378
AC:
32
AN:
84752
European-Finnish (FIN)
AF:
0.0000564
AC:
3
AN:
53236
Middle Eastern (MID)
AF:
0.00106
AC:
6
AN:
5638
European-Non Finnish (NFE)
AF:
0.0000793
AC:
83
AN:
1047138
Other (OTH)
AF:
0.000585
AC:
34
AN:
58084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
43
85
128
170
213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000556
AC:
84
AN:
151104
Hom.:
2
Cov.:
32
AF XY:
0.000528
AC XY:
39
AN XY:
73832
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41520
American (AMR)
AF:
0.0000666
AC:
1
AN:
15014
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.0147
AC:
66
AN:
4484
South Asian (SAS)
AF:
0.000839
AC:
4
AN:
4770
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
67962
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000108
Hom.:
0
Bravo
AF:
0.000835

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
LEOPARD syndrome 2 (1)
-
-
1
Noonan syndrome 5 (1)
-
-
1
RASopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.39
DANN
Benign
0.54
PhyloP100
-0.99
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3730270; hg19: chr3-12650848; API